Develco Pharma

Develco Pharma is a Swiss-German pharmaceutical company specializing in the development and production of oral modified-release, extended-release, and timed-release drugs containing known active ingredients. Established in 2006, the company currently employs 130 people. Develco identifies and defines medications with known active ingredients and develops generic, hybrid, value-added, and innovative formulations supported by clinical data for delaying or modifying the release of active ingredients. With its extensive experience and innovative spirit, the company has become an internationally recognized supplier of drugs for the treatment of multiple therapeutic areas. Develco Pharma's customer base includes global pharmaceutical groups.